For instance in the EPM A compound, the TAC formulation
posted changes of -75.
Based on these studies, we are conducting additional studies to further optimize our methotrexate formulation
in preparation for starting Phase I clinical trials in 1995.
provides excellent flame retardance in large-scale-burn and flame-spread tests such as the Steiner Tunnel test (ASTM E-84).
Class I peroxides are these formulations
that are capable of deflagration but not detonation.
issues around lipid-based oral and parenteral delivery systems
The original formulation
Dyazide will no longer be available from SB.
The recipe, or formulation
section of the program is where the rubber chemist will spend most of the time actually using the program.
SinuNase is a novel application and formulation
of a known anti-fungal exclusively licensed from the Mayo Foundation for Medical Education and Research.
Mathematical models were used to predict optimum formulations
which would provide maximum tensile strength at given hardness levels.
Decapeptyl([R]) is available in monthly or quarterly sustained-release formulations
, as well as a daily formulation
Accentia Biopharmaceuticals (NASDAQ: ABPI) has announced that in a study of chronic sinusitis (CS) patients refractory to sinus surgery, treated with various strengths of extemporaneously prepared pump-spray formulations
of intranasal amphotericin B, a formulation
containing a mid-range concentration of amphotericin B was associated with a significant, 74% reduction in repeat sinus surgery (P=0.
Under the terms of the agreement, Inspire has acquired exclusive rights to further develop and commercialize oral formulations
of bilastine in the United States and Canada, as well as the exclusive right to develop and commercialize the ocular formulation
in various markets worldwide.
Our once-daily CDT-ondansetron formulation
efforts are intended to provide us with a future product opportunity in the growing Cancer Therapy market.
Jeremy Heidel, Chief Scientific Officer, will present data from the study showing that the therapeutic candidate is well tolerated at doses significantly higher than those shown to be efficacious in previous studies using a similar formulation
Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has initiated a Phase I human clinical trial of an inhaled formulation
of ALN-RSV01 in the U.